F.D.A.
PersonMentions
0
Relationships
3
Events
3
Documents
0
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
Event Timeline
Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
3 total relationships
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
Celgene
|
Regulatory oversight adversarial |
7
|
1 | |
|
person
Celgene
|
Regulated by |
6
|
1 | |
|
person
Celgene
|
Regulated entity regulator |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| 1998-12-01 | N/A | The F.D.A. held a meeting to warn Celgene about its marketing of Thalomid for unapproved uses. | N/A | View |
| 1998-01-01 | N/A | The F.D.A. approved Celgene's application to treat erythema nodosum leprosum, a complication of l... | United States | View |
| 1998-01-01 | N/A | Celgene's application was approved by the F.D.A. to treat erythema nodosum leprosum, a complicati... | United States | View |
No documents found for this entity.
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
3
As Recipient
0
Total
3
Marketing of Thalomid
From:
F.D.A.
To:
Celgene
The F.D.A. called a meeting to warn Celgene of its 'strong concern' that the company was marketing Thalomid for unapproved uses.
Meeting / warning
1998-12-01
Marketing of Thalomid
From:
F.D.A.
To:
Celgene
The F.D.A. called a meeting to warn Celgene of its 'strong concern' that the company was marketing Thalomid for unapproved uses.
Meeting / warning
1998-12-01
Marketing of Thalomid
From:
F.D.A.
To:
Celgene
The F.D.A. called a meeting to warn Celgene of its 'strong concern' that the company was marketing Thalomid for unapproved uses.
Meeting / warning
1998-12-01
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity